trial · primary record
Recombinant human interleukin-15 (rhIL-15)
Solid Tumors
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 16 |
| Primary completion | 2015-09-08 |
| Primary endpoint | Toxicity |
| Registry ID | NCT01875601 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:20.005Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT01875601
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.